Frontlight ResearchEarly access
Ovarian cancer trials in France
99 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3CompletedStudy to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Where
- Bordeaux, Chambray-lès-Tours, Grenoble Cedex 9, La Roche Sur Yon Cedex 9, Lyon, Marseille, Rennes Cedex, Strasbourg Cedex 2, Villejuif
- Age
- 18 years and over
- People
- 466 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07214779 · EU 2025-522748-42-00 - No phaseTaking peopleGenetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
- Where
- Marseille
- Age
- 18 years and over
- People
- 5,000
- Run by
- Institut Paoli-Calmettes
See details and how to joinNCT03667417 - Phase 2Taking peopleA Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- Where
- Avignon Cedex 9, Bordeaux, Caen Cedex 5, Dijon, Limoges, Lyon, Nice Cedex 2, Plérin, Reims, Saint-Cloud, Strasbourg, Toulouse, Villejuif
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- AbbVie
See details and how to joinNCT07059845 · EU 2025-521606-18-00 - Phase 1Taking peopleA Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
- Where
- Lyon, Saint-Herblain Cedex, Villejuif
- Age
- 18 years and over
- People
- 285 worldwide
- Run by
- AbbVie
See details and how to joinNCT07278336 · EU 2025-522209-40-00 - Phase 1Taking peoplePhase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- Where
- Pierre-Bénite
- Age
- 15 years and over
- People
- 282 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT06276491 - Phase 1Taking peoplePressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer
- Where
- Lille Cedex, Lyon Cedex 04, Pierre-Bénite
- Age
- 18 years to 75 years
- People
- 15
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT04811703 · EU 2024-515996-37-00 - Phase 1/2Taking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Bordeaux, Clermont-Ferrand, Lyon, Nîmes, Saint-Herblain, Strasbourg, Toulouse, Vandœuvre-lès-Nancy, Villejuif
- Age
- 12 years and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - Phase 1/2Taking peopleStudy of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- Where
- Bordeaux, Caen Cedex 5, Dijon, Lyon, Nice Cedex 2, Pierre-Bénite, Villejuif Cedex
- Age
- 18 years and over
- People
- 890 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT03564340 · EU 2024-510783-23-00 - Phase 1/2Taking peopleA Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- Where
- Bordeaux, Caen Cedex 5, Dijon, Pierre-Bénite, Villejuif
- Age
- 18 years and over
- People
- 612 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT04590326 · EU 2022-501904-83-00 - No phaseTaking peopleImpact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer
- Where
- Besançon, Caen, Clermont-Ferrand, Lyon, Paris, Plérin, Saint-Cloud, Saint-Etienne, Strasbourg, Villejuif
- Age
- 18 years and over
- People
- 268
- Run by
- Centre Francois Baclesse
See details and how to joinNCT06553612 - Phase 2Taking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Bordeaux, Lyon, Suresnes
- Age
- 18 years to 130 years
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - Phase 1/2Taking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Angers, Bordeaux, Bron, Lille, Lyon, Montpellier, Nantes, Strasbourg
- Age
- 18 years and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - No phaseTaking peopleEffect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast Cancer
- Where
- Bordeaux
- Age
- 15 years to 49 years
- People
- 70
- Run by
- Institut Bergonié
See details and how to joinNCT07614620 - Phase 1Taking peopleEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Where
- Lyon, Paris, Saint-Herblain, Villejuif
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT05983432 - No phaseTaking peopleRoutine Shallow-coverage Whole Genome Sequencing Testing of Liquid-based Cervical Smears for the Early Diagnosis of Ovarian Cancer
- Where
- Toulouse
- Age
- 18 years and over
- People
- 50
- Run by
- Institut Claudius Regaud
See details and how to joinNCT07821879 - No phaseTaking peopleAssessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer
- Where
- Nice
- Age
- 18 years to 75 years
- People
- 98
- Run by
- Centre Antoine Lacassagne
See details and how to joinNCT07429487 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Besançon, Levallois-Perret, Marseille, Neuilly, Paris
- Age
- 18 years and over
- People
- 2,285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - No phaseTaking peopleContribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique)
- Where
- Montpellier
- Age
- 18 years and over
- People
- 50
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT07098182 - Phase 2/3Taking peopleRecurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
- Where
- Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Lille, Limoges, Lyon, Marseille, Nantes, Nîmes, Paris, Poitiers, Rennes, Saint-Herblain, Saint-Priest-en-Jarez, Strasbourg, Toulouse, Vandœuvre-lès-Nancy, Villejuif
- Age
- 18 years and over
- People
- 138 worldwide
- Run by
- ARCAGY/ GINECO GROUP
See details and how to joinNCT03651206 - Phase 1Taking peopleStudy to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
- Where
- Bordeaux, Reims
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Duke Street Bio Ltd
See details and how to joinNCT06458712 · EU 2023-508805-26-00 - No phaseTaking peopleCOsegregation of VARiants in Panel of Genes
- Where
- Amiens, Angers, Angoulême, Avignon, Bastia, Besançon, Bordeaux, Bourges, Brest, Caen, Chambéry, Clermont-Ferrand, Colmar, Dijon, Grenoble, La Rochelle, La Roche-sur-Yon, Le Havre, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes, Nice, Nîmes, Niort, Orléans, Paris, Poissy, Poitiers, Reims, Rennes, Rouen, Saint-Cloud, Saint-Etienne, Saint-Herblain, Strasbourg, Toulouse, Tours, Troyes, Valence, Vandœuvre-lès-Nancy, Villejuif
- Age
- 18 years and over
- People
- 11,000 worldwide
- Run by
- Institut Curie
See details and how to joinNCT01689584 - Phase 1Taking peopleA Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
- Where
- Marseille, Villejuif
- Age
- 18 years and over
- People
- 187 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07306559 · EU 2025-522913-45-00 - Phase 1/2Taking peopleA Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Where
- Bordeaux, Lille, Lyon, Nantes, Strasbourg, Strasbourg Cedex 2, Villejuif
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04104776 · EU 2023-508002-20-00 - Phase 2Not yet taking people in FranceContinued Access to Avutometinib in Combination With Defactinib in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)
- Where
- Lyon, Paris
- Age
- 18 years and over
- People
- 2
- Run by
- Verastem, Inc.
See details and how to joinNCT07747506 - Phase 3Taking peopleUtility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery
- Where
- Angers, Avignon, Bayonne, Besançon, Bordeaux, Brest, Caen, Chambray-lès-Tours, Cholet, Clermont-Ferrand, Contamine-sur-Arve, Créteil, Dijon, Grenoble, Le Chesnay, Lille, Limoges, Lyon, Marseille, Montpellier, Mougins, Nantes, Nice, Nîmes, Paris, Pau, Pierre-Bénite, Poissy, Reims, Rennes, Saint-Etienne, Saint-Herblain, Saint-Priest-en-Jarez, Strasbourg, Suresnes, Thonon-les-Bains, Toulouse, Valence, Villejuif
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- ARCAGY/ GINECO GROUP
See details and how to joinNCT06476184